drug

topotecan

1 story · latest Aug 11, 2026

Status: FDA approved May 1996 · NDA020671, NDA020981, NDA200582
Brand: Hycamtin
Trials: 8 registered trials in coverage

Relationships

Developed by Novartis

Developed by Pfizer

Developed by Sandoz

Also known as

topotecan hydrochloride

Timeline

Theriva doses first patients in VIRAGE2 trial of VCN-01 in pancreatic cancer

Aug 11Quarterly updateTheriva Biologics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.